| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6715cf9aa8bf1c8a5ec475b41128e498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee602c630e57f59c6cfc1c1634e36064 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 |
| filingDate |
2007-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74a2c0c15d5c7f1b550eca3b972124da |
| publicationDate |
2009-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2009008901-A2 |
| titleOfInvention |
Peptide and small molecule agonises of epa and their uses in diseases |
| abstract |
A method of treating a neoplastic disorder in a subject includes administering to a Eph kinase expressing neoplastic cell of the subject being treated an EphA agonist and at least one immunosuppressant. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011057251-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9150657-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9808489-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11534466-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8449882-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3648766-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10568912-B2 |
| priorityDate |
2006-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |